APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.
about
APOBEC3B, a molecular driver of mutagenesis in human cancers.Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.Progressive APOBEC3B mRNA expression in distant breast cancer metastases.Co-transcriptional R-loops are the main cause of estrogen-induced DNA damage.The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.Physiological functions of programmed DNA breaks in signal-induced transcription.WeSME: uncovering mutual exclusivity of cancer drivers and beyond.APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian CarcinomaAssessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer.APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.GIGGLE: a search engine for large-scale integrated genome analysis.Viral subversion of APOBEC3s: Lessons for anti-tumor immunity and tumor immunotherapy.Genome-wide analysis reveals a role for TDG in estrogen receptor-mediated enhancer RNA transcription and 3-dimensional reorganization.Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.Transcription-associated events affecting genomic integrity.APOBEC3B Activity Is Prevalent in Urothelial Carcinoma Cells and Only Slightly Affected by LINE-1 Expression
P2860
Q33743603-E34EE656-35F2-4D32-9619-8B372F6A4768Q36013147-1B204F52-AE7C-4D61-9EFA-170A2B47B1D6Q36110285-65457A92-A0FF-498F-B2CB-1191C9E1E293Q36265144-558798E4-406F-41B1-9A9D-9866D9D1059FQ37270352-06EA6EA9-64A6-4FA1-BB30-7DC46CCE0738Q37281847-4D7B4FB0-D4B5-4D17-88A7-B249F2E7FA2CQ37321593-67838993-E9A9-4772-8589-C26DBA5F5D6AQ37594444-6FC352C9-19FB-484D-A6D7-CCDEFA9B641CQ39155253-E153A166-B74D-442F-AEEF-7A7C153A34C8Q39788196-EC51BCCE-514D-4A98-B77B-CAF53CEEAE19Q39888120-9BF653DE-EE4D-4F57-89CE-21DEC70E5A20Q40381692-378A3DAB-B80A-4B42-A3A3-AD159948A771Q40908304-338B950D-A39A-4F4E-ACAA-97AF104EBBF5Q41924608-34A9812C-831D-4A08-A55C-7C24C05B9495Q47152216-E25D8EF6-7727-472C-BEC8-CC78F2648E73Q47194739-0E7D1650-761F-455B-9900-D72C8CE87CB1Q47568875-D4962CA1-D7CA-4274-A0D6-08613F8FF3E9Q49599218-524B8E9B-834B-4D8A-8238-F1925F0B8DEDQ53688854-02CC2CB5-635B-4B1E-96DE-F36809F022F0Q53801893-ABB38AB5-29D3-408C-8E9A-4DAE23C1B5C0Q58764658-524ECC15-9BE4-4761-BCC2-F86B7FEB8EA8
P2860
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
APOBEC3B-Mediated Cytidine Dea ...... eptor Action in Breast Cancer.
@ast
APOBEC3B-Mediated Cytidine Dea ...... eptor Action in Breast Cancer.
@en
type
label
APOBEC3B-Mediated Cytidine Dea ...... eptor Action in Breast Cancer.
@ast
APOBEC3B-Mediated Cytidine Dea ...... eptor Action in Breast Cancer.
@en
prefLabel
APOBEC3B-Mediated Cytidine Dea ...... eptor Action in Breast Cancer.
@ast
APOBEC3B-Mediated Cytidine Dea ...... eptor Action in Breast Cancer.
@en
P2093
P2860
P50
P1433
P1476
APOBEC3B-Mediated Cytidine Dea ...... eptor Action in Breast Cancer.
@en
P2093
Anna Maria Ochocka
Chun-Fui Lai
Ekaterina Nevedomskaya
Frances Fuller-Pace
Hetal Patel
Jason S Carroll
Judit Remenyi
Laki Buluwela
Manikandan Periyasamy
Naveenan Navaratnam
P2860
P304
P356
10.1016/J.CELREP.2015.08.066
P577
2015-09-22T00:00:00Z